T. Rowe Price Associates’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

T. Rowe Price Associates’s Portfolio CMLTU Stock Details CMLTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,292,388	Closed	-$34.3M	–	3086
2021 Q3	$34.3M	Sell	3,292,388 -3,015	-0.1%	-$31.5K	﹤0.01%	1142
2021 Q2	$36.1M	Buy	+3,295,403	New	+$35.5M	﹤0.01%	1143

T. Rowe Price Associates's CMLTU Position: Q4 2021 in Review

T. Rowe Price Associates sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q4 2021, closing a stake of 3,292,388 shares — an estimated $34.3M sold.

T. Rowe Price Associates first reported a position in CMLTU in Q2 2021 and held it in 2 quarters. The position peaked at $36.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold CMLTU as of Q4 2021.

T. Rowe Price Associates reported no remaining CM Life Sciences III Inc. Unit position as of Q4 2021 after selling out during the quarter.
T. Rowe Price Associates sold 3,292,388 CM Life Sciences III Inc. Unit shares in Q4 2021, an estimated $34.3M.
T. Rowe Price Associates first reported a position in CM Life Sciences III Inc. Unit in Q2 2021 and held it in 2 quarters.
T. Rowe Price Associates's CM Life Sciences III Inc. Unit position peaked at $36.1M in Q2 2021.
0 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.